GleamWall
中文EN

CYAN CYANOTECH CORP

Medicinal Chemicals & Botanical Products · OTC · SEC CIK 768408 · Fiscal year ends 03/31

Financial factors as of 2025-09-30 (2025Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY8.5%
TTM net income YoY67.4%
TTM EPS YoY69.9%
Revenue 3-yr CAGR-5.0%
Net income 3-yr CAGR—

Margins

Gross margin32.0%
Operating margin-4.2%
Net margin-7.0%
FCF margin-5.7%
EBITDA margin1.5%

Returns

ROE-20.0%
ROA-7.4%
ROIC (approx.)-5.3%
Asset turnover1.05x

Leverage & solvency

Liabilities / assets66.4%
Debt / equity1.04x
Current ratio1.00x
Interest coverage-1.48x

Cash quality & payout

Operating cash flow / net income0.68x
Accruals ratio-2.4%
Payout ratio—
Capex / revenue0.9%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-03-31FY20242024-03-31
Income statement
Revenue$24.21M$23.07M
Cost of revenue$17.34M$17.13M
Gross profit$6.88M$5.95M
R&D expense$449,000$689,000
SG&A expense$4.40M$4.46M
Operating income-$2.51M-$4.59M
Interest expense$687,000$668,000
Pretax income-$3.19M-$5.26M
Income tax$8,000$7,000
Net income-$3.20M-$5.27M
EBITDA-$1.03M-$3.00M
EPS (basic)-0.45-0.81
EPS (diluted)—-0.81
Weighted avg. shares (diluted)—6,531
Balance sheet
Cash & equivalents$257,000$707,000
Receivables$1.95M$2.10M
Inventory$7.79M$7.31M
Current assets$10.54M$10.59M
PP&E, net$8.93M$10.11M
Total assets$23.49M$25.11M
Current liabilities$10.24M$8.55M
Short-term debt$6.65M$5.63M
Long-term debt$1.00M$1.00M
Total debt$7.65M$6.63M
Total liabilities$14.61M$13.30M
Shareholders' equity$8.88M$11.81M
Net debt$7.39M$5.92M
Shares outstanding7.20M6.95M
Cash flow statement
Operating cash flow-$1.19M-$455,000
Capital expenditure$247,000$381,000
Free cash flow-$1.44M-$836,000
Investing cash flow-$247,000-$381,000
Financing cash flow$990,000$569,000
Depreciation & amortization$1.48M$1.59M
Stock-based compensation$247,000$359,000

Free plan shows the latest 2 periods; Pro shows all 16 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.